These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 39180753

  • 21. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 22. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.
    Wang L, Tang C, Cao H, Li K, Pang X, Zhong L, Dang W, Tang H, Huang Y, Wei L, Su M, Chen T.
    Cancer Biol Ther; 2015 Jul; 16(8):1220-30. PubMed ID: 26121010
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway.
    Xie C, Zhou M, Lin J, Wu Z, Ding S, Luo J, Zhan Z, Cai Y, Xue S, Song Y.
    Biomed Res Int; 2020 Jul; 2020():7804706. PubMed ID: 33029523
    [Abstract] [Full Text] [Related]

  • 25. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
    Xiao W, Liu Y, Dai M, Li Y, Peng R, Yu S, Liu H.
    Int J Mol Med; 2020 Aug; 46(2):700-708. PubMed ID: 32626924
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S, Gonugunta VK, Penugurti V, Malisetty VL, Vadlamudi RK, Manavathi B.
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H, Ding Y, Yang X.
    Biomed Res Int; 2021 Apr; 2021():6619730. PubMed ID: 34250088
    [Abstract] [Full Text] [Related]

  • 32. LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells.
    Zhang X, Song Q, Wei C, Qu J.
    Cell Stress Chaperones; 2015 Jul; 20(4):631-41. PubMed ID: 25860915
    [Abstract] [Full Text] [Related]

  • 33. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y, Ma X, Wang Y, Li G.
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [Abstract] [Full Text] [Related]

  • 34. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
    Hu J, Wang M, Yang Y, Xing Y, Li S.
    Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
    [Abstract] [Full Text] [Related]

  • 35. Tuftelin 1 (TUFT1) Promotes the Proliferation and Migration of Renal Cell Carcinoma via PI3K/AKT Signaling Pathway.
    Lin H, Zeng W, Lei Y, Chen D, Nie Z.
    Pathol Oncol Res; 2021 Oct; 27():640936. PubMed ID: 34257606
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma.
    Feng FQ, Liu GS, Li JC, Chen LZ.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2870-2879. PubMed ID: 31002138
    [Abstract] [Full Text] [Related]

  • 37. P4HA2 contributes to head and neck squamous cell carcinoma progression and EMT through PI3K/AKT signaling pathway.
    Wu YL, Liu W, Zhao T, Jin J.
    Med Oncol; 2024 May 23; 41(6):163. PubMed ID: 38777998
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.